Diseases [C] » Infections [C01] » Bacterial Infections and Mycoses » Bacterial Infections » Gram-Negative Bacterial Infections » Neisseriaceae Infections » Meningococcal Infections
Description
Infections with bacteria of the species NEISSERIA MENINGITIDIS. MeSH
Hierarchy View
Subtype Terms (1)
Meningitis, Meningococcal
42 drugs (31 approved, 11 experimental)
Approved Indicated Drugs (3)
Phase 4 Indicated Drugs (19)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23)
acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia)
Bivalent group A and C meningococcal vaccine (Menomune-A/C)
diphtheria, tetanus and whole cell pertussis vaccine (Boostrix)
glyco-conjugate neisseria meningitidis serogroup c vaccine
haemophilus influenzae type b conjugate vaccine (HibTITER)
hepatitis a vaccine, inactivated (vaqta)
meningococcal conjugate vaccine (Menveo)
Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi)
Phase 3 Indicated Drugs (25)
10-valent Pneumococcal Conjugate Vaccine (Pneumosil)
attenuated measles vaccine - Edmonston strain (rubeovax)
DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine (Pediarix)
hepatitis-a virus (inactivated) / hepatitis-b surface antigen (twinrix)
hepatitis b vaccine (recombinant) (Recombivax)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9)
human rotavirus, live attenuated (Rotarix)
Phase 1 Indicated Drugs (4)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (29)
Canadian Center for Vaccinology
Canadian Immunization Research Network
Canadian Institutes of Health Research (CIHR)
Centro Superior de Investigación en Salud Publica
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (8)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.